Novartis Slips Into Pfizer's Number One Pharma Slot Amid Leaderboard Shakeup

Listen to this article

Pfizer has dropped to number seven in our top pharma rankings after a long reign. AbbVie has risen to number three, growing through merger expansion.

Pfizer Inc. gave up its reign as the number one pharma company in the world based on pharmaceutical revenues in 2020, handing the title to Novartis AG for the first time since 2016 in the Scrip 100 rankings. Novartis's pharmaceutical revenues grew in 2020 while Pfizer strategically pared down its business by spinning out its established products business, a move that dramatically reshaped the company.

Pfizer dropped to number seven in the Scrip 100 rankings after leading almost every year for at least a decade....

Big Three Lead From The Front With Medtech Back On Solid Growth Footing

Dec 13 2022

• By Ashley Yeo

Abbott Laboratories and Johnson & Johnson joined Medtronic in putting a clear distance between themselves and other global medtechs in the Top 10 by revenues for 2021. Post-COVID-19 procedure growth, and, for Abbott, a strong rebound in non-COVID diagnostic demand, were key drivers.

Infographic: Top 100 Pharma Companies

Dec 13 2022

• By Lucie Ellis-Taitt

The Scrip 100 universe gathers FY2021 financial performance data and compares the activities of the top 100 biopharma businesses, ranked by pharma sales.

Pfizer Leads An Unusual Year For The Scrip 100

Dec 13 2022

• By Jessica Merrill

Pfizer catapulted back into the lead in the pharmaceutical rankings on the strength of COVID-19 revenues while BioNTech and Moderna both made the list for the first time.

Outlook 2023: The Pharma Rollercoaster Shows No Signs Of Slowing Down

Dec 12 2022

• By Jo Shorthouse

What will 2023 bring as the industry faces one of the toughest periods in the last decade? In Vivo asked three industry experts for their views.

Scrip 100: By The Numbers

Dec 06 2023

• By Lucie Ellis-Taitt and Kosh Naran

Pfizer dominated the Scrip 100 rankings of the top pharmaceutical companies in the world based on full year 2022 pharmaceutical sales, driven by its COVID-19 success.